Chlorpromazine oligomer is a potentially active substance that inhibits human D-amino acid oxidase, product of a susceptibility gene for schizophrenia

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 23, Issue 6, 2008, Pages 901-911

  Iwana, Sanae ^a   Kawazoe, Tomoya ^a   Park, Hwan K I ^a   Tsuchiya, Koichiro ^a   Ono, Koji ^a   Yorita, Kazuko ^a   Sakai, Takashi ^a   Kusumi, Takenori ^a   Fukui, Kiyoshi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Chlorpromazine; D Amino acid oxidase; Glutamatergic neurotransmission; Inhibition; Oligomer; Schizophrenia

Indexed keywords

CHLORPROMAZINE; DEXTRO AMINO ACID OXIDASE; DRUG METABOLITE; NEUROLEPTIC AGENT; OLIGOMER;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC SUSCEPTIBILITY; HUMAN; LIGHT IRRADIANCE; MASS SPECTROMETRY; NONHUMAN; OLIGOMERIZATION; PHOTOALLERGY; PHOTOTOXICITY; PRIORITY JOURNAL; SCHIZOPHRENIA; STRUCTURE ANALYSIS; SWINE;

CHLORPROMAZINE; D-AMINO-ACID OXIDASE; ENZYME INHIBITORS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; PHOTOCHEMISTRY; SCHIZOPHRENIA; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

SUS;

EID: 56449117143     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360701745478     Document Type: Article

References (45)

1. Fukui, K., Watanabe, F., Shibata, T. and Miyake, Y. (1987) Molecular cloning and sequence analysis of cDNAs encoding porcine kidney d-amino acid oxidase. Biochemistry, 26, pp. 3612-3618.
2. Momoi, K., Fukui, K., Watanabe, F. and Miyake, Y. (1988) Molecular cloning and sequence analysis of cDNA encoding human kidney d-amino acid oxidase. FEBS Lett, 238, pp. 180-184.
3. Fukui, K., Momoi, K., Watanabe, F. and Miyake, Y. (1988) In vivo and in vitro expression of porcine d-amino acid oxidase: In vitro system for the synthesis of a functional enzyme. Biochemistry, 27, pp. 6693-6697.
4. Fukui, K. and Miyake, Y. (1992) Molecular cloning and chromosomal localization of a human gene encoding d-amino-acid oxidase. J Biol Chem, 267, pp. 18631-18638.
5. Urai, Y., Jinnouchi, O., Kwak, KT, Suzue, A., Nagahiro, S. and Fukui, K. (2002) Gene expression of d-amino acid oxidase in cultured rat astrocytes: Regional and cell type specific expression. Neurosci Lett, 324, pp. 101-104.
6. Park, HK, Shishido, Y., Ichise-Shishido, S., Kawazoe, T., Ono, K., Iwana, S., Tomita, Y., Yorita, K., Sakai, T. and Fukui, K. (2006) Potential role for astroglial d-amino acid oxidase in extracellular d-serine metabolism and cytotoxicity. J Biochem (Tokyo), 139, pp. 295-304.
7. Sawa, A. and Snyder, SH (2002) Schizophrenia: Diverse approaches to a complex disease. Science, 296, pp. 692-695.
8. Chumakov, I., Blumenfeld, M., Guerassimenko, O., Cavarec, L., Palicio, M., Abderrahim, H., Bougueleret, L., Barry, C., Tanaka, H. La Rosa, P. et al. (2002) Genetic and physiological data implicating the new human gene G72 and the gene for -amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA, 99, pp. 13675-13680.
9. Yagi, K., Nagatsu, T. and Ozawa, T. (1956) Inhibitory action of chlorpromazine on the oxidation of d-amino-acid in the diencephalon part of the brain. Nature, 177, pp. 891-892.
10. Yeung, PKF, Hubbard, JW, Cooper, JK and Midha, KK (1983) A study of the kinetics of chlorpromazine sulfoxide by a specific radioimmunoassay after a single oral dose of chlorpromazine in healthy volunteers. J Pharmacol Exp Ther, 226, pp. 833-838.
11. (1969) An extra pharmacopoeia companion volume: Isolation and identification of drugs in pharmaceuticals, body fluids and post-mortem material, pp. 256-257. Pharmaceutical Press, London
12. Ljunggren, B. (1977) Phenothiazine phototoxicity: Toxic chlorpromazine photoproducts. J Invest Dermatol, 69, pp. 383-386.
13. Menz, J., Muller, SA and Connolly, SM (1988) Photopatch testing: A six-year experience. J Am Acad Dermatol, 18, pp. 1044-1047.
14. Chignell, CF, Motten, AG and Buettner, GR (1985) Photoinduced free radicals from chlorpromazine and related phenothiazines: Relationship to phenothiazine-induced photosensitization. Environ Health Perspect, 64, pp. 103-110.
15. Wollemann, M. and Elodi, P. (1961) Die Hemmung der kristallisierten d-glyceraldehyd-3-phosphat dehydrogenase aktivitat durch phenothiazine und aminoketone. [Inhibition of crystallized -glyceraldehyde-3-phosphate dehydrogenase activity by phenothiazine and aminoketone.]. Biochem Pharmacol, 6, pp. 228-232.
16. Akera, T. and Brody, TM (1972) Effects of chlorpromazine free radical on brain microsomal enzymes. Biochem Pharmacol, 21, pp. 1403-1411.
17. Muraoka, S. and Miura, T. (2003) Inactivation of cholinesterase induced by chlorpromazine cation radicals. Pharmacol Toxicol, 92, pp. 100-104.
18. Piette, LH, Bulow, G. and Yamazaki, I. (1964) Electron-paramagnetic-resonance studies of the chlorpromazine free radical formed during enzymic oxidation by peroxidase-hydrogen peroxide. Biochim Biophys Acta, 88, pp. 120-129.
19. Ljunggren, B. and Moller, H. (1977) Phenothiazine phototoxicity: An experimental study on chlorpromazine and its metabolites. J Invest Dermatol, 68, pp. 313-317.
20. Cavanaugh, DJ (1957) Oxidation of chlorpromazine by peroxidase and catalase. Science, 125, pp. 1040-1041.
21. Van Woert, MH (1968) Isolation of chlorpromazine pigments in man. Nature, 219, pp. 1054-1056.
22. Huang, CL (1967) Isolation and identification of urinary chlorpromazine metabolites in man. Int J Neuropharmacol, 6, pp. 1-13.
23. Forrest, IS, Forrest, FM and Berger, M. (1958) Free radicals as metabolites of drugs derived from phenothiazine. Biochim Biophys Acta, 29, pp. 441-442.
24. Kawazoe, T., Tsuge, H., Pilone, MS and Fukui, K. (2006) Crystal structure of human d-amino acid oxidase: Context-dependent variability of the backbone conformation of the VAAGL hydrophobic stretch located at the si-face of the flavin ring. Protein Sci, 15, pp. 2708-2717.
25. Massey, V. and Curti, B. (1966) A new method of preparation of d-amino acid oxidase apoprotein and a conformational change after its combination with flavin adenine dinucleotide. J Biol Chem, 241, pp. 3417-3423.
26. Raibekas, AA, Fukui, K. and Massey, V. (2000) Design and properties of human d-amino acid oxidase with covalently attached flavin. Proc Natl Acad Sci USA, 97, pp. 3089-3093.
27. Molla, G., Sacchi, S., Bernasconi, M., Pilone, MS, Fukui, K. and Pollegioni, L. (2006) Characterization of human d-amino acid oxidase. FEBS Lett, 580, pp. 2358-2364.
28. Setoyama, C., Nishina, Y., Tamaoki, H., Mizutani, H., Miyahara, I., Hirotsu, K., Shiga, K. and Miura, R. (2002) Effects of hydrogen bonds in association with flavin and substrate in flavoenzyme d-amino acid oxidase. The catalytic and structural roles of Gly313 and Thr317. J Biochem (Tokyo), 131, pp. 59-69.
29. Miyano, M., Fukui, K., Watanabe, F., Takahashi, S., Tada, M., Kanashiro, M. and Miyake, Y. (1991) Studies on Phe-228 and Leu-307 recombinant mutants of porcine kidney d-amino acid oxidase: Expression, purification, and characterization. J Biochem (Tokyo), 109, pp. 171-177.
30. Yagi, K., Ozawa, T. and Nagatsu, T. (1960) Mechanism of inhibition of d-amino acid oxidase. IV. Inhibitory action of chlorpromazine. Biochim Biophys Acta, 43, pp. 310-317.
31. Gabay, S. and Harris, SR (1967) Studies of flavin-adenine dinucleotide-requiring enzymes and phenothiazines. 3. Inhibition kinetics with highly purified -amino acid oxidase. Biochem Pharmacol, 16, pp. 803-812.
32. Gabay, S. and Harris, SR (1965) Studies of flavin adenine dinucleotide-requiring enzymes and phenothiazines-I. Interactions of chlorpromazine and -amino acid oxidase. Biochem Pharmacol, 14, pp. 17-26.
33. Vazquez, A., Tudela, J., Varon, R. and Garcia-Canovas, F. (1992) Determination of the molar absorptivities of phenothiazine cation radicals generated by oxidation with hydrogen peroxide/peroxidase. Anal Biochem, 202, pp. 245-248.
34. Carlsson, M. and Carlsson, A. (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease. Trends Neurosci, 13, pp. 272-276.
35. Coyle, JT (1996) The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatry, 3, pp. 241-253.
36. Tsai, G., Yang, P., Chung, LC, Lange, N. and Coyle, JT (1998) -Serine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry, 44, pp. 1081-1089.
37. Yamamoto, BK and Cooperman, MA (1994) Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations. J Neurosci, 14, pp. 4159-4166.
38. Brandish, PE, Chiu, CS, Schneeweis, J., Brandon, NJ, Leech, CL, Kornienko, O., Scolnick, EM, Strulovici, B. and Zheng, W. (2006) A cell-based ultra-high-throughput screening assay for identifying inhibitors of d-amino acid oxidase. J Biomol Screen, 11, pp. 481-487.
39. Pinto, J., Huang, YP and Rivlin, RS (1981) Inhibition of riboflavin metabolism in rat tissues by chlorpromazine, imipramine, and amitriptyline. J Clin Invest, 67, pp. 1500-1506.
40. Huang, CL and Sands, FL (1967) Effect of ultraviolet irradiation on chlorpromazine. II. Anaerobic condition. J Pharm Sci, 56, pp. 259-264.
41. Sgaragli, GP, Ninci, R., Della Corte, L., Valoti, M., Nardini, M., Andreoli, V. and Moneti, G. (1986) Promazine: A major plasma metabolite of chlorpromazine in a population of chronic schizophrenics. Drug Metab Dispos, 14, pp. 263-266.
42. Mizuno, Y., Sato, K., Sano, T., Kurihara, R., Kojima, T., Yamakawa, Y., Ishii, A. and Katsumata, Y. (2002) Identification and characterization of 17 phenothiazine compounds by capillary high-performance liquid chromatography/fast atom bombardment mass spectrometry. Leg Med (Tokyo), 4, pp. 207-216.
43. Sgaragli, GP, Valoti, M., Palmi, M., Frosini, M., Giovannini, MG, Bianchi, L. and Della Corte, L. (1995) Rat tissue concentrations of chlorimipramine, chlorpromazine and their N-demethylated metabolites after a single oral dose of the parent compounds. J Pharm Pharmacol, 47, pp. 782-790.
44. Sato, S. and Koshiro, A. (1995) Pharmacokinetic analysis of chlorpromazine in rat serum, cerebrospinal fluid and striatum. Biol Pharm Bull, 18, pp. 593-599.
45. Wajnberg, E., Tabak, M., Nussenzveig, PA, Lopes, CMB and Louro, SRW (1988) pH-dependent phase transition of chlorpromazine micellar solutions in the physiological range. Biochim Biophys Acta, 944, pp. 185-190.